VITILIGO
Clinical trials for VITILIGO explained in plain language.
Never miss a new study
Get alerted when new VITILIGO trials appear
Sign up with your email to follow new studies for VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New skin ointment aims to bring back color in vitiligo
Disease control OngoingThis study is testing an ointment called MH004 to see if it can help restore skin color in people with non-segmental vitiligo. About 156 adolescents and adults will use the ointment or a placebo for 24 weeks, followed by a longer safety period. The main goal is to see how well it…
Matched conditions: VITILIGO
Phase: PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Major trial tests promising pill to restore skin color in vitiligo
Disease control OngoingThis large, late-stage study is testing if a daily pill called upadacitinib can help repigment skin in people with non-segmental vitiligo, an autoimmune condition that causes white patches. About 614 participants will be randomly assigned to receive either the active drug or a pl…
Matched conditions: VITILIGO
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New cream aims to bring color back to Vitiligo-Affected skin
Disease control OngoingThis study is testing a new topical cream called SHR0302Base to see if it can safely help restore skin color in people with nonsegmental vitiligo. About 155 participants will be randomly assigned to receive either the active cream or an inactive version to compare results. The ma…
Matched conditions: VITILIGO
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Early trial tests new shot for skin condition
Disease control OngoingThis early-stage trial is testing the safety of an experimental medication called TEV-53408 for adults with vitiligo, a condition that causes loss of skin color. The study will involve 38 participants who will receive injections under the skin over 24 weeks, followed by a long mo…
Matched conditions: VITILIGO
Phase: PHASE1 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
New cream trial aims to bring color back to vitiligo skin
Disease control OngoingThis study is testing whether a daily cream containing rapamycin can help restore skin color in people with vitiligo. Participants will apply one of two strengths of the cream to a patch of skin on one side of their body and a placebo cream to a matching patch on the other side f…
Matched conditions: VITILIGO
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
Scientists probe genetic clues to skin condition
Knowledge-focused OngoingThis study aims to understand the link between a specific gene (TRPM2) and a part of the immune system (NLRP3 inflammasome) in people with vitiligo. Researchers will compare blood samples from 60 adults with vitiligo to see if genetic differences are connected to how severe the c…
Matched conditions: VITILIGO
Sponsor: Aswan University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC